Clinical Trial Update: A Positron-Emission-Tomography (PET) Study to Measure the Blockade of Dopamine Receptors (D2) in Specific Areas of the Brain in Relation to the Plasma Concentrations of Paliperidone Extended Release (ER) and Oral Risperidone in Schizophrenia Patients and Healthy Controls [Phase 4]

View source ↗

Summary

Phase 4 PET study assessing D2 receptor occupancy in relation to plasma levels of paliperidone ER and risperidone in schizophrenia patients and healthy controls…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Paliperidone ER (paliperidone)
• RISPERIDONE (RISPERIDONE)

Snippet

Sponsor: Janssen-Cilag G.m.b.H | Conditions: Schizophrenia | Phase 4 | Status: TERMINATED | Results posted: 2011-01-11